<DOC>
	<DOCNO>NCT02180542</DOCNO>
	<brief_summary>The purpose study improve secondary prevention ischemic stroke patient 1 . Estimating prevalence prognostic significance frequent premature atrial complex ischemic stroke patient relation death , recurrent stroke atrial fibrillation . 2 . Characterize ischemic stroke patient 1 . Echocardiographic characteristic 2 . Biochemical marker 3 . Plaque composition carotid artery - order improve risk stratification .</brief_summary>
	<brief_title>Atrial Fibrillation Premature Atrial Complexes Patients With Ischemic Stroke .</brief_title>
	<detailed_description>Patients atrial fibrillation ( AF ) five-fold increase risk ischemic stroke compare general population . Identifying AF challenging , prolong rhythm monitoring ischemic stroke patient show enhance detection rate AF . Therefore important identify predictor AF allow target screening patient ischemic stroke thereby reduce recurrent stroke rate . Few former study show association excessive number premature atrial complex ( PACs ) AF . The study population ischemic stroke patient admission undergo follow examination : 1 . ECG 2 . 48 hour inpatient cardiac telemetry ( If know AF ) 3 . 24 hour holter monitoring ( know AF ) 4. echocardiogram 5. blood sample 6 . CT scan carotid artery contrast make Dual Energy CT scan . In follow-up period , patient two visit 48 hour holter monitoring ( 6 12 month , respectively ) It notice patient recurrent event , die og develop AF . The study population divide four group follow : 1. patient new AF admission 2. patient know AF 3. patient frequent PACs 4. patient without frequent PACs . These group compare baseline characteristic outcome mention . The overall perspective make good strategy detect occult AF ischemic stroke improve secondary stroke prevention care .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Atrial Premature Complexes</mesh_term>
	<criteria>admit ischemic stroke single center time diagnose inclusion maximum 7 day . write informed consent surrogate inform consent eligible age &gt; 18 year . hemorrhagic stroke terminal illness expect lifespan less 6 month . physical mental condition make patient unsuitable participation study . know pacemaker anticoagulation treatment reason atrial fibrillation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>stroke</keyword>
	<keyword>Ischemic stroke</keyword>
	<keyword>Cerebral infarction</keyword>
	<keyword>recurrent stroke</keyword>
	<keyword>atrial fibrillation</keyword>
	<keyword>premature atrial complex</keyword>
	<keyword>heart rhythm monitoring</keyword>
	<keyword>leave atrial function</keyword>
	<keyword>carotid artery</keyword>
	<keyword>plaque morphology</keyword>
</DOC>